Clinical outcomes of multisite moderate to high dose radiotherapy for patients with metastatic melanomaOA
Clinical outcomes of multisite moderate to high dose radiotherapy for patients with metastatic melanoma
Kelly H.Li;Patrick CF.Cheung;Teresa M.Petrella;Liying Zhang;Ian DT.Poon;Ines B.Menjak
Department of Medical Oncology,BC Cancer Agency,Vancouver,CanadaDepartment of Radiation Oncology,Odette Cancer Centre,Toronto,Sunnybrook Health Sciences Centre,Toronto,CanadaDepartment of Medical Oncology,Odette Cancer Centre,Sunnybrook Health Sciences Centre,Toronto,CanadaMacrostat Incorporated,Toronto,CanadaDepartment of Radiation Oncology,Odette Cancer Centre,Toronto,Sunnybrook Health Sciences Centre,Toronto,CanadaDepartment of Medical Oncology,Odette Cancer Centre,Sunnybrook Health Sciences Centre,Toronto,Canada
immunotherapylocal controlmetastatic melanomaprogression-free survivalradiotherapy
immunotherapylocal controlmetastatic melanomaprogression-free survivalradiotherapy
《精准放射肿瘤学(英文)》 2024 (2)
62-69,8
评论